We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $8.34B
1-Year Est. Return 165.53%
This Fund
S&P 500
This Quarter Est. Return
+77.9%
1 Year Est. Return
+165.53%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.34B
AUM Growth
+$2.35B
Cap. Flow
-$42M
Cap. Flow %
-0.5%
Top 10 Hldgs %
46.57%
Holding
644
New
20
Increased
132
Reduced
424
Closed
57

Top Buys

Rank Stock Value
1
INIO
INNIO N.V.
INIO
+$177M
2
AMD icon
Advanced Micro Devices
AMD
+$119M
3
FORM icon
FormFactor
FORM
+$101M
4
CBRS
Cerebras Systems
CBRS
+$70.1M
5
ONTO icon
Onto Innovation
ONTO
+$64.5M

Top Sells

Rank Stock Value
1
TSEM icon
Tower Semiconductor
TSEM
+$220M
2
LITE icon
Lumentum
LITE
+$219M
3
TSLA icon
Tesla
TSLA
+$50.1M
4
CIEN icon
Ciena
CIEN
+$43.3M
5
MSFT icon
Microsoft
MSFT
+$42.6M

Sector Composition

Rank Sector Weight
1 Technology 66.11%
2 Communication Services 9.64%
3 Consumer Discretionary 8.42%
4 Industrials 4.35%
5 Healthcare 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIOA
476
BioAge Labs
BIOA
$440M
$22.6K ﹤0.01%
921
+124
+16% +$2.24K
PCRX icon
477
Pacira BioSciences
PCRX
$1.05B
$21.8K ﹤0.01%
860
-107
-11% -$2.53K
OLMA icon
478
Olema Pharmaceuticals
OLMA
$941M
$21.2K ﹤0.01%
1,698
-69
-4% -$924
ETON icon
479
Eton Pharmaceutcials
ETON
$1.67B
$20.6K ﹤0.01%
569
-28
-5% -$821
KURA icon
480
Kura Oncology
KURA
$1.18B
$20.2K ﹤0.01%
1,843
-101
-5% -$953
JANX icon
481
Janux Therapeutics
JANX
$1.24B
$19.8K ﹤0.01%
1,289
-53
-4% -$768
VOR icon
482
Vor Biopharma
VOR
$1.48B
$19.7K ﹤0.01%
1,072
+700
+188% +$10.6K
SANA icon
483
Sana Biotechnology
SANA
$1.15B
$19.7K ﹤0.01%
5,637
-321
-5% -$1.03K
RLJ icon
484
RLJ Lodging Trust
RLJ
$1.67B
$19.7K ﹤0.01%
1,659
-420
-20% -$3.93K
ABUS icon
485
Arbutus Biopharma
ABUS
$1.02B
$19.5K ﹤0.01%
4,071
-229
-5% -$1.01K
SLDB icon
486
Solid Biosciences
SLDB
$1.1B
$19.4K ﹤0.01%
1,946
+207
+12% +$1.57K
AMPH icon
487
Amphastar Pharmaceuticals
AMPH
$986M
$19.4K ﹤0.01%
963
-61
-6% -$1.23K
REPL icon
488
Replimune Group
REPL
$1.42B
$19.4K ﹤0.01%
1,750
-2
-0.1% -$12
MRVI icon
489
Maravai LifeSciences
MRVI
$1.09B
$19.3K ﹤0.01%
3,099
-142
-4% -$613
TBPH icon
490
Theravance Biopharma
TBPH
$887M
$18.3K ﹤0.01%
1,076
-53
-5% -$877
GRFS
491
Grifois
GRFS
$5.31B
$18.3K ﹤0.01%
2,582
-143
-5% -$1.13K
PHAT icon
492
Phathom Pharmaceuticals
PHAT
$769M
$18.1K ﹤0.01%
1,669
+81
+5% +$924
ANNX icon
493
Annexon
ANNX
$923M
$17.5K ﹤0.01%
3,065
-169
-5% -$934
DSGN icon
494
Design Therapeutics
DSGN
$947M
$17.5K ﹤0.01%
1,209
-62
-5% -$773
GERN icon
495
Geron
GERN
$1.01B
$17.3K ﹤0.01%
13,506
-727
-5% -$1.02K
ZVRA icon
496
Zevra Therapeutics
ZVRA
$736M
$17.1K ﹤0.01%
1,194
-62
-5% -$689
SPRY icon
497
ARS Pharmaceuticals
SPRY
$559M
$16.8K ﹤0.01%
2,094
-114
-5% -$981
UMH
498
UMH Properties
UMH
$1.36B
$16.6K ﹤0.01%
1,097
-138
-11% -$2.11K
AAT
499
American Assets Trust
AAT
$1.35B
$16.4K ﹤0.01%
665
-76
-10% -$1.67K
CTMX icon
500
CytomX Therapeutics
CTMX
$808M
$16.1K ﹤0.01%
4,302
+515
+14% +$1.97K
18 19
20
21 22

Similar funds

GLF
Groupe la Francaise Paris, France $8.31B AUM 37.53% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
MWM
Modern Wealth Management Lenexa, Kansas $8.4B AUM 21.02% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
OCA
OpenArc Corporate Advisory Atlanta, Georgia $8.41B AUM

GF Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, GF Fund Management held 644 positions worth $8.34B, up 39% from $5.98B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

GF Fund Management's Q2 2026 filing shows 20 new, 132 increased, 424 reduced and 57 closed positions. Its largest new stake was INNIO N.V.: 4,970,000 shares worth $197M. The largest sale was Tower Semiconductor, an estimated $220M.

By sector, the portfolio is most concentrated in Technology at 66% of assets, up from 54% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q2 2026 buy was INNIO N.V.: 4,970,000 shares worth $197M.
  • GF Fund Management added most to Advanced Micro Devices in Q2 2026, an estimated $119M increase.
  • GF Fund Management's biggest Q2 2026 reduction was Tower Semiconductor, cutting an estimated $220M.
  • GF Fund Management fully exited Coherent in Q2 2026, selling an estimated $23.3M.
  • GF Fund Management's ten largest holdings make up 47% of its $8.34B portfolio in Q2 2026.
  • GF Fund Management opened 20 new positions and closed 57 in Q2 2026.
  • GF Fund Management's portfolio value rose 39% quarter-over-quarter to $8.34B.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.